John L. Brottem - Mar 15, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
General Counsel
Signature
John L Brottem
Stock symbol
OM
Transactions as of
Mar 15, 2022
Transactions value $
-$191,709
Form type
4
Date filed
3/15/2022, 07:56 PM
Previous filing
Mar 2, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $9.48K +1K +2.72% $9.48 37.8K Mar 15, 2022 Direct
transaction OM Common Stock Sale -$38.6K -1K -2.65% $38.59 36.8K Mar 15, 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $53K +5.59K +15.18% $9.48 42.4K Mar 15, 2022 Direct
transaction OM Common Stock Sale -$216K -5.59K -13.18% $38.59 36.8K Mar 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.59K -12.35% $0.00 39.6K Mar 15, 2022 Common Stock 5.59K $9.48 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -1K -23.45% $0.00 3.27K Mar 15, 2022 Common Stock 1K $9.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 - 3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F4 This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.